Residue-resolved insights into the stabilization of therapeutic proteins by excipients: A case study of two monoclonal antibodies with arginine and glutamate

Protein formulation development relies on the selection of excipients that inhibit protein–protein interactions preventing aggregation. Empirical strategies involve screening many excipient and buffer combinations by physicochemical characterization using forced degradation or temperature-induced st...

Full description

Saved in:
Bibliographic Details
Main Authors: Tobias M. Prass, Patrick Garidel, Lars V. Schäfer, Michaela Blech
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:mAbs
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19420862.2024.2427771
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items